Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children

Paul S. Lietman; Sheldon Kaplan; Edward Mason; Sally K. Mason; Francis I. Catlin; Rita T. Lee; Mary Murphy; Ralph D. Feigin

doi:10.1016/S0022-3476(84)81115-4

Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children

Paul S. Lietman, Sheldon Kaplan, Edward Mason, Sally K. Mason, Francis I. Catlin, Rita T. Lee, Mary Murphy, Ralph D. Feigin

Research Institute

Research output: Contribution to journal › Article

37 Scopus citations

Abstract

In a prospective, randomized study, moxalactam in 44 children was compared with amplicillin or chloramphenicol in 47 children for the treatment of Haemophilus influenzae type b meningitis. Both groups were comparable in terms of clinical and laboratory findings at admission. The hospital course, neurologic sequelae including deafness, and number of deaths were the same for both groups. The incidence of adverse reactions also was the same except that diarrhea and thrombocytosis occurred significantly (P≤0.04) more frequently in children given moxalactam. Moxalactam was equivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in children.

Original language	English (US)
Pages (from-to)	447-453
Number of pages	7
Journal	The Journal of Pediatrics
Volume	104
Issue number	3
DOIs	https://doi.org/10.1016/S0022-3476(84)81115-4
State	Published - Jan 1 1984

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1016/S0022-3476(84)81115-4

Fingerprint Dive into the research topics of 'Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children'. Together they form a unique fingerprint.

Cite this

Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children. / Lietman, Paul S.; Kaplan, Sheldon; Mason, Edward; Mason, Sally K.; Catlin, Francis I.; Lee, Rita T.; Murphy, Mary; Feigin, Ralph D.

In: The Journal of Pediatrics, Vol. 104, No. 3, 01.01.1984, p. 447-453.

Research output: Contribution to journal › Article

@article{c0202364a8634d079996199926809528,

title = "Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children",

abstract = "In a prospective, randomized study, moxalactam in 44 children was compared with amplicillin or chloramphenicol in 47 children for the treatment of Haemophilus influenzae type b meningitis. Both groups were comparable in terms of clinical and laboratory findings at admission. The hospital course, neurologic sequelae including deafness, and number of deaths were the same for both groups. The incidence of adverse reactions also was the same except that diarrhea and thrombocytosis occurred significantly (P≤0.04) more frequently in children given moxalactam. Moxalactam was equivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in children.",

author = "Lietman, {Paul S.} and Sheldon Kaplan and Edward Mason and Mason, {Sally K.} and Catlin, {Francis I.} and Lee, {Rita T.} and Mary Murphy and Feigin, {Ralph D.}",

year = "1984",

month = jan,

day = "1",

doi = "10.1016/S0022-3476(84)81115-4",

language = "English (US)",

volume = "104",

pages = "447--453",

journal = "Journal of Pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children

AU - Lietman, Paul S.

AU - Kaplan, Sheldon

AU - Mason, Edward

AU - Mason, Sally K.

AU - Catlin, Francis I.

AU - Lee, Rita T.

AU - Murphy, Mary

AU - Feigin, Ralph D.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - In a prospective, randomized study, moxalactam in 44 children was compared with amplicillin or chloramphenicol in 47 children for the treatment of Haemophilus influenzae type b meningitis. Both groups were comparable in terms of clinical and laboratory findings at admission. The hospital course, neurologic sequelae including deafness, and number of deaths were the same for both groups. The incidence of adverse reactions also was the same except that diarrhea and thrombocytosis occurred significantly (P≤0.04) more frequently in children given moxalactam. Moxalactam was equivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in children.

AB - In a prospective, randomized study, moxalactam in 44 children was compared with amplicillin or chloramphenicol in 47 children for the treatment of Haemophilus influenzae type b meningitis. Both groups were comparable in terms of clinical and laboratory findings at admission. The hospital course, neurologic sequelae including deafness, and number of deaths were the same for both groups. The incidence of adverse reactions also was the same except that diarrhea and thrombocytosis occurred significantly (P≤0.04) more frequently in children given moxalactam. Moxalactam was equivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in children.

UR - http://www.scopus.com/inward/record.url?scp=0021345528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021345528&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(84)81115-4

DO - 10.1016/S0022-3476(84)81115-4

M3 - Article

C2 - 6368777

AN - SCOPUS:0021345528

VL - 104

SP - 447

EP - 453

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -